• Register
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.


Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.


Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cells.

Lyn kinase functions as a regulator of imatinib sensitivity in chronic myelogenous leukemia (CML) cells through an unknown mechanism. In patients who fail imatinib therapy but have no detectable BCR-ABL kinase mutation, we detected persistently activated Lyn kinase. In imatinib-resistant CML cells and patients, Lyn activation is BCR-ABL independent, it is complexed with the Gab2 and c-Cbl adapter/scaffold proteins, and it mediates persistent Gab2 and BCR-ABL tyrosine phosphorylation in the presence or absence of imatinib. Lyn silencing or inhibition is necessary to suppress Gab2 and BCR-ABL phosphorylation and to recover imatinib activity. Lyn also negatively regulates c-Cbl stability, whereas c-Cbl tyrosine phosphorylation is mediated by BCR-ABL. These results suggest that Lyn exists as a component of the BCR-ABL signaling complex and, in cells with high Lyn expression or activation, BCR-ABL kinase inhibition alone (imatinib) is not sufficient to fully disengage BCR-ABL-mediated signaling and suggests that BCR-ABL and Lyn kinase inhibition are needed to prevent or treat this form of imatinib resistance.

Pubmed ID: 18235045


  • Wu J
  • Meng F
  • Lu H
  • Kong L
  • Bornmann W
  • Peng Z
  • Talpaz M
  • Donato NJ



Publication Data

April 1, 2008

Associated Grants

  • Agency: NCI NIH HHS, Id: P01 CA 49639

Mesh Terms

  • Adaptor Proteins, Signal Transducing
  • Benzamides
  • Drug Resistance, Neoplasm
  • Enzyme Activation
  • Fusion Proteins, bcr-abl
  • Gene Silencing
  • Humans
  • K562 Cells
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Multiprotein Complexes
  • Mutation
  • Phosphorylation
  • Piperazines
  • Protein Kinase Inhibitors
  • Proto-Oncogene Proteins c-cbl
  • Pyrimidines
  • Signal Transduction
  • src-Family Kinases